Two new clinical trials available for MPN patients
Click here to learn more about current clinical trials for PV, ET, and MF patients.
|
Vactosertib
This is a 2-tiered, Phase
2, Rule-based, Intra-
patient Dose Escalation
Study to Investigate Safety
and Feasibility of
Vactosertib (TEW-7197)
in the Treatment of Anemic
Patients With Philadelphia
Chromosome-negative
MPNs (Ph-neg MPNs).
Read the full
description here
Status: Not yet recruiting
|
PRT543
This is a Phase 1 cohort,
dose-escalation study of
PRT543 inpatients with
advanced cancers who
have exhausted available
treatment options. The
purpose of this study is to
define a safe dose and
schedule to be used in the development of PRT543.
Read the full
description here
Status: Recruiting
|
11/06/19
